Company / Accounts Receivable
VIEMED HEALTHCARE, INC. Accounts Receivable History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$25.6M
FY2025
5-year range
$12.8M / $25.6M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 6 consecutive years, from $12M in FY2019 to $26M in FY2025.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of +15.6%.
Improved from $18M to $26M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +18.5%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- VIEMED HEALTHCARE, INC.'s accounts receivable has grown for 6 consecutive years.
- 5-year CAGR of +15.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 2.7% year-over-year.
- Lowest accounts receivable in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.6M | +2.7% |
| FY2024 | $24.9M | +35.0% |
| FY2023 | $18.5M | +20.0% |
| FY2022 | $15.4M | +19.9% |
| FY2021 | $12.8M | +3.6% |
| FY2020 | $12.4M | +7.3% |
| FY2019 | $11.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026